SEC Tracker
Get the app

Regeneron Pharmaceuticals REGN

Jason Pitofsky (SVP Controller) sold 4,062 REGN at $942.19, worth $3.8M

Form
4
Filed
Importance
Routine
  1. Jason Pitofsky acquired 1,500 shares at $726.53
  2. Sold 439 shares at $939.57
  3. Sold 575 shares at $940.46
  4. Sold 982 shares at $941.58

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Regeneron Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Zoetis ZTS public float $69.2B, Jun 30, 2025
  2. Idexx Laboratories IDXX public float $42.9B, Jun 30, 2025
  3. Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025
  4. Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
  5. Gilead Sciences GILD public float $103.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.